Trial Profile
Examination of the effect of a combination of benzbromarone and febuxostat in patients with hyperuricemia complicating diabetic nephropathy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 May 2016
Price :
$35
*
At a glance
- Drugs Febuxostat (Primary)
- Indications Diabetic nephropathies; Hyperuricaemia
- Focus Therapeutic Use
- 16 May 2016 New trial record